![Jennifer Huber](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jennifer Huber formerly worked at AN2 Therapeutics, Inc., as Senior Vice President-Regulatory Affairs & Quality from 2022 to 2024.
Ms. Huber received her undergraduate degree from Vanderbilt University and graduate degree from The Pennsylvania State University.
| Bedrijven | Functie | Einde |
|---|---|---|
| AN2 THERAPEUTICS, INC. | Algemeen Adviseur | 01-08-2024 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 3 |
|---|---|
Vanderbilt University
 Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AN2 Therapeutics, Inc.
 AN2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
